Dear John, Thank you, we have made note of your second. Kind Regards, Andrea From: Gnso-secs <gnso-secs-bounces@icann.org> on behalf of John McElwaine <john.mcelwaine@nelsonmullins.com> Date: Monday, December 7, 2020 at 17:50 To: PAMELALITTLE <pam.little@alibaba-inc.com>, "council@gnso.icann.org" <council@gnso.icann.org> Cc: "gnso-secs@icann.org" <gnso-secs@icann.org> Subject: Re: [gnso-secs] [council] Motion on GNSO Council Input on Recommendation 7, EPDP Phase 1 Final Report I second Pam’s motion. Best regards, John From: council <council-bounces@gnso.icann.org> On Behalf Of PAMELALITTLE Sent: Monday, December 7, 2020 6:01 PM To: council@gnso.icann.org Cc: gnso-secs@icann.org Subject: [council] Motion on GNSO Council Input on Recommendation 7, EPDP Phase 1 Final Report ◄External Email► - From: council-bounces@gnso.icann.org<mailto:council-bounces@gnso.icann.org> Dear Councilors, Please find attached a motion on GNSO Council Input on Recommendation 7 of the Expedited Policy Development Process (EPDP) on the Temporary Specification for gTLD Registration Data Phase 1 Final Report and Thick Whois Transition Policy, to be considered at the GNSO Council meeting on 17 December 2020 at 12:00 UTC. Respectfully submitted, Pam Little Nelson Mullins is continuing to monitor developments related to COVID-19, including guidance from the Centers for Disease Control and various health officials; and federal, state, and local government authorities. The firm has implemented precautionary measures and plans to ensure the continuation of all firm services to clients from both in office and remote work arrangements across our 25 geographically disperse offices. Click here to visit the Nelson Mullins Coronavirus Resources page. [nelsonmullins.com]<https://urldefense.com/v3/__https:/www.nelsonmullins.com/coronavirus-resourc...> Information described therein is subject to change. Confidentiality Notice This message is intended exclusively for the individual or entity to which it is addressed. This communication may contain information that is proprietary, privileged, confidential or otherwise legally exempt from disclosure. If you are not the named addressee, you are not authorized to read, print, retain, copy or disseminate this message or any part of it. If you have received this message in error, please notify the sender immediately either by phone (800-237-2000) or reply to this e-mail and delete all copies of this message.